Histiocytic syndromes are disorders resulting from a proliferation of the monocyte-macrophage lineage. The clinicopathological presentation varies enormously between the different disorders. A congenital benign localized form affecting the foot is described.
CASE HISTORY
A healthy Caucasian male was delivered by emergency Caesarean section at 41 weeks' gestation, following a normal pregnancy to a 25-year-old primigravida. At birth a 1 em, solitary, reddish-brown, ulcerated nodule was noted on the sole of the foot (Figure 1 ). General examination was entirely normal. An excision biopsy was performed under local anaesthesia in the neonatal period. The wound was left to heal by secondary intention. Histology showed an ulcerated epidermis and a dermal infiltrate of lymphocytes and eosinophils with islands of large, pale histiocytes ( Figure  2 ). Immunohistochemical staining with S-100 identified these as Langerhans' cell histiocytes. Routine investigations excluded systemic involvement. Therefore a diagnosis of congenital self-healing histiocytosis (CSHH) was made. The wound healed uneventfully, with no signs of recurrence 3 months post-operatively ( Figure 3 ).
DISCUSSION
Histiocytic syndromes represent a wide spectrum of clinical disease. These are classified as: (i) Langerhans' cell; (ii) non-Langerhans' cell; and (iii) malignant histiocytosis", The first group is further sub-divided according to whether the disease is systemic (histiocytosis X; HX) or localized (CSSH).
CSHH was first described in 1973 by Hashimoto and Pritzker/. Only 36 cases have been reported in the literature to date '. Typically, it presents at birth, with solitary or multiple skin nodules. These undergo spontaneous regression at 3--4 months and never recur. The male to female It is impossible to differentiate between CSHH and HX on the basis of histology and immunohistochemistry alone.
Once a histological diagnosis of Langerhans' cell histiocytosis has been made, CSHH can be diagnosed clinically by excluding systemic disease. It is important to distinguish beween the two, as HX carries a poorer prognosis, usually requiring aggressive chemotherapy. Recently, electron microscopy studies" have shown that differences do exist between the two. Ultrastructurally, the histiocytes in CSHH display fewer Birbeck granules but more regular laminated dense bodies within the cytoplasm.
Although CSHH is a rarely reported condition, it may not be as uncommon as it appears. Many such lesions may go unrecognized, since they regress rapidly and are seldom biopsied. Therefore, CSHH should be considered in the differential diagnosis of all congenital nodular skin lesions. In these circumstances, an excision biopsy may be indicated for cosmetic and diagnostic purposes.
